Literature DB >> 22830362

Peanut seed storage proteins are responsible for clinical reactivity in Spanish peanut-allergic children.

María Pedrosa1, Teresa Boyano-Martínez, María Carmen García-Ara, Teresa Caballero, Santiago Quirce.   

Abstract

BACKGROUND: Seed storage proteins (SSP; Ara h 1, Ara h 2, Ara h 3) have been shown to be major peanut allergens, although recently, peanut lipid transfer protein has been reported to be an important allergen in the Mediterranean area. We sought to investigate the sensitization pattern to peanut SSP and vegetable pan-allergens in a group of peanut-allergic children compared with a peanut-tolerant group.
METHODS: One hundred and twenty-three children who presented with food allergy were included in the study. Tolerance to peanut ingestion was assessed. Specific IgE was determined by ImmunoCAP, and microarray ISAC was performed. Sensitization frequencies and levels of specific IgE were compared between groups.
RESULTS: Fifty-five of 123 children presented symptoms upon contact or ingestion. Frequency of sensitization to Ara h 1, Ara h 2, and Ara h 3 was 60.0%, 72.7%, and 43.6%, respectively, in the group of allergic children vs. 7.4%, 1.5%, and 7.4% in the group of tolerant children. Levels of specific IgE against Ara h 1, Ara h 2, and Ara h 3 were significantly higher in the allergic group (p < 0.001). The frequency of sensitization and the levels of specific IgE against Cor a 8 (36.4% vs. 16.2%) were significantly higher in the allergic children, whereas no significant differences were found for Pru p 3. No differences were seen for other pan-allergens. Patients sensitized to SSP, regardless of sensitization to nsLTP, were allergic rather than tolerant.
CONCLUSION: In our population, peanut-allergic children were mainly sensitive to SSP. A few patients were also sensitive to some nsLTPs. No differences were shown in other pan-allergens.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22830362     DOI: 10.1111/j.1399-3038.2012.01337.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  7 in total

1.  Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut.

Authors:  Audrey E Koid; Martin D Chapman; Robert G Hamilton; Ronald van Ree; Serge A Versteeg; Stephen C Dreskin; Stef J Koppelman; Sabina Wünschmann
Journal:  J Agric Food Chem       Date:  2013-12-26       Impact factor: 5.279

2.  Diagnosis and treatment of pediatric food allergy: an update.

Authors:  Pasquale Comberiati; Francesca Cipriani; Alina Schwarz; Daniela Posa; Cristina Host; Diego G Peroni
Journal:  Ital J Pediatr       Date:  2015-02-19       Impact factor: 2.638

3.  Peanut sensitization pattern in Norwegian children and adults with specific IgE to peanut show age related differences.

Authors:  Ellen Namork; Berit A Stensby
Journal:  Allergy Asthma Clin Immunol       Date:  2015-11-14       Impact factor: 3.406

Review 4.  Recent advances on diagnosis and management of childhood asthma and food allergies.

Authors:  Dani Hakimeh; Salvatore Tripodi
Journal:  Ital J Pediatr       Date:  2013-12-27       Impact factor: 2.638

Review 5.  Using Component-Resolved Diagnostics in the Management of Peanut-Allergic Patients.

Authors:  F C van Erp; R J B Klemans; Y Meijer; C K van der Ent; A C Knulst
Journal:  Curr Treat Options Allergy       Date:  2016-04-07

6.  Sensitization to PR-10 proteins is indicative of distinctive sensitization patterns in adults with a suspected food allergy.

Authors:  Mark A Blankestijn; André C Knulst; Edward F Knol; Thuy-My Le; Heike Rockmann; Henny G Otten; Rob J B Klemans
Journal:  Clin Transl Allergy       Date:  2017-11-23       Impact factor: 5.871

7.  Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children.

Authors:  H K Brand; M W J Schreurs; J A M Emons; R Gerth van Wijk; H de Groot; N J T Arends
Journal:  Clin Mol Allergy       Date:  2021-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.